<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-81821</identifier>
<setSpec>1699-8855</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Poorly differentiated Sertoli-Leydig cell tumour of the ovary with heterologous endodermal colonic type tissue</dc:title>
<dc:description xml:lang="en">Introduction. Sertoli-Leydig cell tumours (SLCT) of the ovary are rare, accounting for only 1% of all sex cord-stromal tumours and are formed by Sertoli and Leydig cells and/or fibroblasts in different proportions and various degrees of differentiation. Sometimes they may contain heterologous elements, such as mucinous epithelium, cartilage, skeletal muscle and/or carcinoid and therefore should be considered in the differential diagnosis of various types of tumours. Methods. The clinical, histological and immunohistochemical features of a case of Sertoli Leydig tumour of the ovary are presented and the literature is reviewed. Sections were stained with hematoxylin-eosin and immunohistochemistry using the streptavidin-biotin-peroxidase method for CD56, S-100 protein, cytokeratin (AE1/AE and 20), CEA, vimentin, inhibin, calretinin and CDX2 was performed. Results and conclusions. The tumour had a characteristic appearance, being composed mainly of stromal cells with few Sertoli cell tubules, admixed with Leydig cells. Immunohistochemistry confirmed the diagnosis(AU)</dc:description>
<dc:creator>Solís García, Eduardo</dc:creator>
<dc:creator>González Serrano, Teresa</dc:creator>
<dc:creator>Ruiz Molina, Inmaculada</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción. Los tumores de células de Sertoli-Leydig (TCSL) de ovario son neoplasias infrecuentes que suponen el 1% de todos los tumores de los cordones sexuales estromal, estando constituidas por células de Sertoli, células de Leydig y/o células fibroblásticas en proporciones diferentes y con varios niveles de diferenciación. En ocasiones estos tumores contienen elementos heterólogos del tipo epitelio mucinoso, cartílago, músculo estriado y/o carcinoide, que pueden remedar a otras neoplasias y provocan errores diagnósticos. Método. Se ha realizado una revisión de los datos clínicos, analíticos, las características histológicas y de la literatura médica. Se han seleccionado cortes representativos los cuales han sido teñidos con hematoxilina eosina y posteriormente se ha realizado estudio inmunohistoquímico con el método estreptavidina biotina peroxidasa para CD56, proteina S-100, citoqueratinas (AE1/AE 3), CEA, vimentina, inhibina, calretinina y CDX2. Resultado y conclusión. La neoplasia está constituida por una población preferentemente estromal con escasos grupos de túbulos y cordones correspondientes a células de Sertoli entremezcladas con células de Leydig, sueltas o en nidos, de aspecto característico al de los tumores de esta estirpe(AU)</dc:description>
<dc:source>Rev. esp. patol;43(3): 151-154, jul.-sept.2010. ilus</dc:source>
<dc:identifier>ibc-81821</dc:identifier>
<dc:title xml:lang="es">Tumor de células de Sertoli-Leydig poco diferenciado de ovario con elementos heterólogos endodérmicos de tipo colónico</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d30496^s22053</dc:subject>
<dc:subject>^d31050^s22053</dc:subject>
<dc:subject>^d31050^s22012</dc:subject>
<dc:subject>^d32842</dc:subject>
<dc:subject>^d22921^s22045</dc:subject>
<dc:subject>^d10230^s22004</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d3965</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d10229^s22053</dc:subject>
<dc:subject>^d10230^s22053</dc:subject>
<dc:subject>^d33495</dc:subject>
<dc:type>article</dc:type>
<dc:date>201009</dc:date>
</metadata>
</record>
</ibecs-document>
